WASHINGTON, March 22 (Reuters) - The United States would equitably integrate AstraZeneca’s COVID-19 vaccine into the distribution system if the vaccine is approved by U.S. authorities, White House Press Secretary Jen Psaki said on Monday.
She noted there was still a vaccine shortage in the United States and some 1,400 people were still dying each day.
AstraZeneca’s COVID-19 vaccine performed better than expected in a major late-stage trial, the drugmaker said on Monday, potentially paving the way for its emergency authorization in the United States.
Reporting by Steve Holland; writing by Andrea Shalal
Our Standards: The Thomson Reuters Trust Principles.